Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
August 3, 2015
CIDARA THERAPEUTICS INITIATES PHASE 1 STUDY OF LEAD ANTIFUNGAL PRODUCT CANDIDATE CD101 IV
June 12, 2015
RUTHIGEN AND PULMATRIX STOCKHOLDERS APPROVE MERGER
June 4, 2015
ARVINAS PUBLISHES FIRST PEER-REVIEWED PAPER ON ITS PROPRIETARY PROTAC TECHNOLOGY
May 25, 2015
CHINESE CONSORTIUM ENTERS INTO AGREEMENT TO ACQUIRE AMBRX
May 11, 2015
AUDENTES THERAPEUTICS ANNOUNCES NEW DATA TO BE PRESENTED AT AMERICAN SOCIETY OF GENE AND CELL THERAPY ANNUAL MEETING
May 11, 2015
FDA GRANTS QIDP AND FAST TRACK DESIGNATIONS TO CD101 IV, CIDARA THERAPEUTICS’ LEAD ANTIFUNGAL PRODUCT CANDIDATE
May 7, 2015
SPYRYX BIOSCIENCES SECURES $18 MILLION IN SERIES A FINANCING
April 30, 2015
THE MEDICINES COMPANY ANNOUNCES FDA APPROVAL OF IONSYS® (FENTANYL IONTOPHORETIC TRANSDERMAL SYSTEM) FOR THE MANAGEMENT OF ACUTE POST-OPERATIVE PAIN FOR ADULT PATIENTS IN THE HOSPITAL
April 21, 2015
SCPHARMACEUTICALS ANNOUNCES START OF PIVOTAL TRIAL FOR NOVEL FUROSEMIDE SOLUTION FOR SUBCUTANEOUS DELIVERY
April 16, 2015
MALLINCKRODT COMPLETES ACQUISITION OF IKARIA
« Previous Page
1
…
95
96
97
98
99
…
118
Next Page »